The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
111173336 11117333 6 F 20150416 20160824 20150515 20160830 EXP PHHY2014BR166514 NOVARTIS 43.13 YR F Y 57.00000 KG 20160830 CN BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
111173336 11117333 1 PS GILENYA FINGOLIMOD HYDROCHLORIDE 1 Oral 0.5 MG, QD SA656/SC766 22527 .5 MG CAPSULE QD
111173336 11117333 2 C EXODUS//ESCITALOPRAM OXALATE ESCITALOPRAM OXALATE 1 Oral 20 MG, QD 0 20 MG TABLET QD
111173336 11117333 3 C EXODUS//ESCITALOPRAM OXALATE ESCITALOPRAM OXALATE 1 0 TABLET
111173336 11117333 4 C EXODUS//ESCITALOPRAM OXALATE ESCITALOPRAM OXALATE 1 0 TABLET
111173336 11117333 5 C LEXAPRO ESCITALOPRAM OXALATE 1 Oral 1 DF, QD 0 1 DF TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
111173336 11117333 1 Multiple sclerosis
111173336 11117333 2 Multiple sclerosis
111173336 11117333 3 Depression
111173336 11117333 4 Mood altered
111173336 11117333 5 Depression

Outcome of event

Event ID CASEID OUTC COD
111173336 11117333 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
111173336 11117333 Abdominal discomfort
111173336 11117333 Abdominal distension
111173336 11117333 Alanine aminotransferase abnormal
111173336 11117333 Alanine aminotransferase increased
111173336 11117333 Aspartate aminotransferase increased
111173336 11117333 Back injury
111173336 11117333 Central nervous system lesion
111173336 11117333 Crying
111173336 11117333 Dizziness
111173336 11117333 Dyspnoea
111173336 11117333 Eye pain
111173336 11117333 Fall
111173336 11117333 Fatigue
111173336 11117333 Gamma-glutamyltransferase increased
111173336 11117333 Headache
111173336 11117333 Hypotension
111173336 11117333 Influenza
111173336 11117333 Irritability
111173336 11117333 Mood altered
111173336 11117333 Muscular weakness
111173336 11117333 Musculoskeletal stiffness
111173336 11117333 Paraesthesia
111173336 11117333 Photophobia
111173336 11117333 Tremor
111173336 11117333 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
111173336 11117333 1 201410 0
111173336 11117333 2 201401 0
111173336 11117333 5 201411 0